Pages that link to "Q44053396"
Jump to navigation
Jump to search
The following pages link to A long-term clinical trial of interferon alpha-therapy in essential thrombocythemia (Q44053396):
Displaying 13 items.
- Treatment of polycythaemia vera and essential thrombocythaemia (Q33820416) (← links)
- Essential thrombocythemia (ET): moving from palliation to cure (Q35022117) (← links)
- A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms (Q37955231) (← links)
- Successful Management of Hydroxyurea-induced Leg Ulcers in Essential Thrombocythemia: Report of 3 Cases. (Q38175389) (← links)
- Issues in the diagnosis and management of essential thrombocythemia (Q40663379) (← links)
- The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update (Q40953190) (← links)
- Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers (Q41253192) (← links)
- New drugs in essential thrombocythemia and polycythemia vera (Q41527295) (← links)
- Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term alpha-IFN treatment (Q70751303) (← links)
- Interferon therapy of hematologic malignancies (Q74548938) (← links)
- Long term treatment of myeloproliferative disease with interferon-alpha-2b: feasibility and efficacy (Q77308651) (← links)
- Interferon alpha therapy for patients with essential thrombocythemia: final results of a phase II study initiated in 1986 (Q81699492) (← links)
- Interferon alpha therapy in essential thrombocythemia and polycythemia vera-a systematic review and meta-analysis (Q99637214) (← links)